Cargando…

Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis

BACKGROUND: Bile acids are important endocrine modulators of intestinal and hepatic signalling cascades orchestrating critical pathophysiological processes in various liver diseases. Increasing knowledge on bile acid signalling has stimulated the development of synthetic ligands of nuclear bile acid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simbrunner, Benedikt, Trauner, Michael, Reiberger, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290708/ https://www.ncbi.nlm.nih.gov/pubmed/34555862 http://dx.doi.org/10.1111/apt.16602

Ejemplares similares

Gut-liver axis signaling in portal hypertension
por: Simbrunner, Benedikt, et al.
Publicado: (2019)

Recent advances in the understanding and management of hepatorenal syndrome
por: Simbrunner, Benedikt, et al.
Publicado: (2021)

An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis
por: Hartl, Lukas, et al.
Publicado: (2023)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
por: Zhang, Yu-Lin, et al.
Publicado: (2022)

Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis
por: de Haan, Lianne, et al.
Publicado: (2018)

The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics
por: Ridlon, Jason M., et al.
Publicado: (2015)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis
por: Grüner, Niklas, et al.
Publicado: (2021)

Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19
por: Hartl, Lukas, et al.
Publicado: (2021)

Renin/angiotensin system-coagulation-inflammation axis abnormalities: a possible explanation for susceptibility to severe COVID-19 in cirrhosis
por: Hartl, Lukas, et al.
Publicado: (2022)

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
por: Arab, Juan P., et al.
Publicado: (2016)

Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Bile acid transporters and regulatory nuclear receptors in the liver and beyond
por: Halilbasic, Emina, et al.
Publicado: (2013)

Rethinking the bile acid/gut microbiome axis in cancer
por: Phelan, John P., et al.
Publicado: (2017)

The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation
por: Hartl, Lukas, et al.
Publicado: (2023)

Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver–Gut Axis
por: Liu, Linlin, et al.
Publicado: (2020)

COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality
por: Hartl, Lukas, et al.
Publicado: (2021)

Low mortality despite temporary liver dysfunction in severe courses of acute hepatitis E
por: Bauer, David J. M., et al.
Publicado: (2022)

Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
por: Radun, Richard, et al.
Publicado: (2021)

Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression
por: Jachs, Mathias, et al.
Publicado: (2022)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Therapeutic Roles of Bile Acid Signaling in Chronic Liver Diseases
por: Li, Yan, et al.
Publicado: (2018)

Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure
por: Balcar, Lorenz, et al.
Publicado: (2021)

Liver Capsule: FXR agonists against liver disease
por: Fuchs, Claudia D., et al.
Publicado: (2016)

Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
por: Simbrunner, Benedikt, et al.
Publicado: (2020)

Zhuyu Pill Alleviates Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism through the Gut–Liver Axis
por: Xu, Lu, et al.
Publicado: (2023)

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
por: Balcar, Lorenz, et al.
Publicado: (2023)

Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence
por: Steininger, Lisa, et al.
Publicado: (2020)

Functional, Diagnostic and Therapeutic Aspects of Bile
por: Ahmed, Monjur
Publicado: (2022)

Safety of direct oral anticoagulants in patients with advanced liver disease
por: Semmler, Georg, et al.
Publicado: (2021)

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(−/−) mice by modulating composition, signalling and excretion of faecal bile acids
por: Fuchs, Claudia Daniela, et al.
Publicado: (2018)

MRI‐defined sarcopenia predicts mortality in patients with chronic liver disease
por: Beer, Lucian, et al.
Publicado: (2020)

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
por: Yang, Chao, et al.
Publicado: (2021)

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
por: Wei, Meilin, et al.
Publicado: (2020)

Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
por: Mulak, Agata
Publicado: (2021)

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
por: Li, Lingfeng, et al.
Publicado: (2022)

Adequate scattergram interpretation increases the reliability of automated polymorphonuclear (pmn) cell counts from ascitic fluid of patients with liver cirrhosis
por: Haslacher, Helmuth, et al.
Publicado: (2021)

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease
por: Balcar, Lorenz, et al.
Publicado: (2022)

Incidence, phenotype and prognostic relevance of COVID-19-related liver injury across different age strata
por: Hartl, Lukas, et al.
Publicado: (2022)

Role of bile acids in liver diseases mediated by the gut microbiome
por: Shao, Jun-Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qb26kgq9mf6as0ti5hon4c31qi